dc.contributor.author | Gören Şahin, Deniz | |
dc.contributor.author | Özçelik, Nurcan | |
dc.contributor.author | Kurt Yıldırım, Burcu | |
dc.contributor.author | Hindilerden, Fehmi | |
dc.contributor.author | Güvenç, Serkan | |
dc.contributor.author | Sami Göksoy, Hasan | |
dc.contributor.author | Reyhan Küçükkaya, Diz | |
dc.contributor.author | Tülay Özçelik, Emine | |
dc.date.accessioned | 2021-12-21T08:31:14Z | |
dc.date.available | 2021-12-21T08:31:14Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1016-9113 | |
dc.identifier.issn | 2147-6500 | |
dc.identifier.uri | https://app.trdizin.gov.tr/makale/TXpnMk5qZzVPUT09/miyelofibrozisli-olgularda-allojenik-kok-hucre-nakil-sonuclarimiz-tek-merkezli-retrospektif-bir-analiz | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/645 | |
dc.description.abstract | Amaç: Primer miyelofibrozis (PMF), kronik miyeloproliferasyon, atipik megakaryositik hiperplazi vekem k l ğ f broz s le karakter ze klonal b r kök hücre hastalığıdır. Bu hastalarda günümüzde halengöster leb lm ş tek şifa sağlayıcı tedavi seçeneği olan all | |
dc.description.abstract | Aim: Primary myelofibrosis (PMF) is a clonal stem cell disease characterized by chronic
myeloproliferation, atypical megakaryocytic hyperplasia and bone marrow fibrosis. Allogeneic stem cell
transplantation, which is the only curative treatment option, | |
dc.language.iso | Turkish | |
dc.title | Miyelofibrozisli olgularda allojenik kök hücre nakil sonuçlarımız: tek
merkezli, retrospektif bir analiz | |
dc.title.alternative | Allogeneic stem cell transplantation in patients with myelofibrosis: single center, retrospective study | |
dc.relation.journal | Ege Tıp Dergisi | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 109 | |
dc.identifier.endpage | 112 | |
dc.identifier.volume | 59 | |
dc.relation.issue | 2 | |
dc.relation.volume | 59 | |